$1.08 Earnings Per Share Expected for Danaher Co. (DHR) This Quarter

Share on StockTwits

Wall Street brokerages predict that Danaher Co. (NYSE:DHR) will announce $1.08 earnings per share for the current fiscal quarter, according to Zacks Investment Research. Six analysts have issued estimates for Danaher’s earnings, with the lowest EPS estimate coming in at $1.05 and the highest estimate coming in at $1.10. Danaher posted earnings per share of $1.00 during the same quarter last year, which suggests a positive year-over-year growth rate of 8%. The company is scheduled to report its next quarterly earnings report on Thursday, October 18th.

On average, analysts expect that Danaher will report full year earnings of $4.49 per share for the current financial year, with EPS estimates ranging from $4.43 to $4.54. For the next year, analysts expect that the business will report earnings of $4.84 per share, with EPS estimates ranging from $4.40 to $5.00. Zacks’ earnings per share averages are a mean average based on a survey of sell-side analysts that cover Danaher.

Danaher (NYSE:DHR) last issued its earnings results on Thursday, July 19th. The conglomerate reported $1.15 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.09 by $0.06. The firm had revenue of $4.98 billion during the quarter, compared to analysts’ expectations of $4.91 billion. Danaher had a net margin of 13.84% and a return on equity of 11.55%. The firm’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period last year, the firm posted $0.99 earnings per share.

A number of equities analysts recently commented on DHR shares. Zacks Investment Research lowered shares of Danaher from a “buy” rating to a “hold” rating in a research note on Tuesday, July 24th. Morgan Stanley raised their price objective on shares of Danaher from $120.00 to $122.00 and gave the stock an “overweight” rating in a research note on Friday, July 20th. Royal Bank of Canada raised their price objective on shares of Danaher to $107.00 and gave the stock a “positive” rating in a research note on Thursday, July 19th. They noted that the move was a valuation call. Bank of America set a $113.00 price objective on shares of Danaher and gave the stock a “buy” rating in a research note on Thursday, July 19th. Finally, ValuEngine raised shares of Danaher from a “hold” rating to a “buy” rating in a research note on Thursday, July 12th. Two research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $108.31.

NYSE:DHR traded down $1.38 during trading hours on Friday, reaching $100.33. 1,763,721 shares of the company’s stock were exchanged, compared to its average volume of 2,776,131. The stock has a market capitalization of $71.17 billion, a price-to-earnings ratio of 24.90, a PEG ratio of 1.95 and a beta of 1.04. Danaher has a 12 month low of $79.10 and a 12 month high of $106.08. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.07 and a current ratio of 1.50.

In other Danaher news, SVP Robert S. Lutz sold 14,555 shares of Danaher stock in a transaction on Tuesday, July 24th. The shares were sold at an average price of $103.93, for a total transaction of $1,512,701.15. Following the completion of the sale, the senior vice president now owns 18,044 shares of the company’s stock, valued at approximately $1,875,312.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Thomas Patrick Joyce, Jr. sold 104,913 shares of Danaher stock in a transaction on Tuesday, July 31st. The shares were sold at an average price of $101.88, for a total transaction of $10,688,536.44. Following the sale, the insider now directly owns 276,438 shares of the company’s stock, valued at approximately $28,163,503.44. The disclosure for this sale can be found here. Insiders have sold a total of 196,875 shares of company stock valued at $20,246,147 in the last three months. Company insiders own 11.90% of the company’s stock.

Several large investors have recently modified their holdings of the business. Securian Asset Management Inc boosted its stake in shares of Danaher by 0.8% during the 2nd quarter. Securian Asset Management Inc now owns 62,119 shares of the conglomerate’s stock valued at $6,130,000 after buying an additional 504 shares during the period. Gulf International Bank UK Ltd boosted its stake in shares of Danaher by 0.3% during the 1st quarter. Gulf International Bank UK Ltd now owns 197,012 shares of the conglomerate’s stock valued at $19,289,000 after buying an additional 520 shares during the period. Renaissance Investment Group LLC boosted its stake in shares of Danaher by 0.7% during the 2nd quarter. Renaissance Investment Group LLC now owns 74,099 shares of the conglomerate’s stock valued at $7,312,000 after buying an additional 525 shares during the period. First Mercantile Trust Co. boosted its stake in shares of Danaher by 10.1% during the 2nd quarter. First Mercantile Trust Co. now owns 5,732 shares of the conglomerate’s stock valued at $566,000 after buying an additional 526 shares during the period. Finally, Advisory Services Network LLC raised its holdings in shares of Danaher by 3.4% during the 2nd quarter. Advisory Services Network LLC now owns 16,351 shares of the conglomerate’s stock valued at $1,697,000 after purchasing an additional 543 shares in the last quarter. 76.51% of the stock is owned by institutional investors.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

Featured Story: Trading Penny Stocks

Get a free copy of the Zacks research report on Danaher (DHR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.